Blood pool ventriculography with a new technetium-labelled complex (99mTc-DEPIC): a clinical evaluation.
A new, single bolus method of in vivo blood pool imaging using a technetium Tc99m phosphine isocyanide complex (DEPIC) which binds to pre-albumin was evaluated in volunteers (n = 4) and patients (n = 20). DEPIC was assessed for its safety and possible drug interactions. Its duration of action and quality of ventriculography were compared with imaging using standard in vivo red cell labelling (PYP) during two 3-h scanning periods 1 week apart. DEPIC had a mean plasma half-life of 3.3 h. The count rate over the left ventricle was initially 42% higher with DEPIC than with PYP. However, removal of DEPIC by the liver resulted in equivalent count rates by 1 h, and by 3 h PYP count rates were 22% higher than DEPIC. Immediately post injection mean (SD) difference in the left ventricular ejection fraction between the two methods was 2.4% (7.7%). Satisfactory DEPIC scans were obtained up to 2 h post injection, but by 3 h there was a mean difference of 13% (11.3%). DEPIC was found to be a safe alternative to red all labelling for blood pool angiography, suitable for routine work. The single bolus methodology and high initial count rates offer improved efficiency and a capability for truly emergency scanning.
Brigden
G
G
Department of Cardiology, Northwick Park Hospital and Clinical Research Centre, Harrow, Middlesex, UK.
Zanelli
G
G
Lahiri
A
A
Raftery
E
E
D003485:Cyanates / Q000737:chemistry; D005260:Female; D015637:Gated Blood-Pool Imaging; D006801:Humans; D017953:Isocyanates; D008297:Male; D008875:Middle Aged; D009943:Organophosphorus Compounds / Q000737:chemistry; D013318:Stroke Volume; D013667:Technetium
D003485:Cyanates; D017953:Isocyanates; D009943:Organophosphorus Compounds; C060185:diethoxyphosphoryl isocyanate; D013667:Technetium